Literature DB >> 8144958

Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides.

L R Dick1, C Aldrich, S C Jameson, C R Moomaw, B C Pramanik, C K Doyle, G N DeMartino, M J Bevan, J M Forman, C A Slaughter.   

Abstract

The identification of genes in the class II region of the MHC that are homologous to genes encoding subunits of the proteasome has led to intense interest in the possible role of this enzyme in the proteolytic processing of polypeptide Ags. We have tested the ability of the 20S proteasome to produce peptides that can be presented by class I molecules as targets for killing by OVA-specific and beta-galactosidase-specific CTL clones. Samples of intact OVA and beta-galactosidase were subjected to digestion in vitro by 20S proteasome purified from bovine red cells and the resulting peptide mixtures were fractionated by reverse-phase HPLC. The fractions were tested for their ability to sensitize appropriate mouse target cells for lysis by specific CTL clones. In both cases, components that under all chromatographic conditions eluted with retention times indistinguishable from synthetic peptides representing known epitopes of the naturally processed proteins were found to be able to sensitize the target cells. Moreover, in the case of OVA, the presence of the expected target peptides was demonstrated directly by amino acid sequence and mass spectrometric analysis. The results demonstrate that the pure 20S proteasome is capable of generating antigenic peptides from two proteins for presentation by class I molecules without the participation of additional components of the protein degradation system. This finding is consistent with the hypothesis of proteasome involvement in Ag processing in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144958      PMCID: PMC2778727     

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Ham-2 corrects the class I antigen-processing defect in RMA-S cells.

Authors:  M Attaya; S Jameson; C K Martinez; E Hermel; C Aldrich; J Forman; K F Lindahl; M J Bevan; J J Monaco
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

Review 2.  Proteasomes: protein and gene structures.

Authors:  K Tanaka; T Tamura; T Yoshimura; A Ichihara
Journal:  New Biol       Date:  1992-03

3.  Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene.

Authors:  C K Martinez; J J Monaco
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

4.  Exact prediction of a natural T cell epitope.

Authors:  O Rötzschke; K Falk; S Stevanović; G Jung; P Walden; H G Rammensee
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

5.  Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex.

Authors:  V Ortiz-Navarrete; A Seelig; M Gernold; S Frentzel; P M Kloetzel; G J Hämmerling
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

6.  The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.

Authors:  M A Bednarek; S Y Sauma; M C Gammon; G Porter; S Tamhankar; A R Williamson; H J Zweerink
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

7.  Second proteasome-related gene in the human MHC class II region.

Authors:  A Kelly; S H Powis; R Glynne; E Radley; S Beck; J Trowsdale
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

8.  Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes.

Authors:  L C Eisenlohr; J W Yewdell; J R Bennink
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

9.  Extracellular processing of peptide antigens that bind class I major histocompatibility molecules.

Authors:  L A Sherman; T A Burke; J A Biggs
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules.

Authors:  S Kozlowski; M Corr; T Takeshita; L F Boyd; C D Pendleton; R N Germain; J A Berzofsky; D H Margulies
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  54 in total

1.  Protective cytotoxic T lymphocyte responses induced by DNA immunization against immunodominant and subdominant epitopes of Listeria monocytogenes are noncompetitive.

Authors:  T Yamada; H Uchiyama; T Nagata; M Uchijima; T Suda; K Chida; H Nakamura; Y Koide
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.

Authors:  Stéphanie Mercier; Hanne Gahéry-Segard; Martine Monteil; Renée Lengagne; Jean-Gérard Guillet; Marc Eloit; Caroline Denesvre
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

4.  A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates.

Authors:  H G Holzhütter; P M Kloetzel
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

5.  Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

6.  Mechanism of antigen presentation after hypertonic loading of soluble antigens.

Authors:  Georg A Enders
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

7.  Immunoproteasome responds to injury in the retina and brain.

Authors:  Deborah A Ferrington; Stacy A Hussong; Heidi Roehrich; Rebecca J Kapphahn; Shannon M Kavanaugh; Neal D Heuss; Dale S Gregerson
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

8.  Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step.

Authors:  Mark G Delboy; Devin G Roller; Anthony V Nicola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

9.  Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data.

Authors:  Yu-feng Lu; Hao Sheng; Yi Zhang; Zhi-yang Li
Journal:  J Zhejiang Univ Sci B       Date:  2013-09       Impact factor: 3.066

10.  The relationship of lmp2 and DR3 genes with susceptibility to type I diabetes mellitus in south China Han population.

Authors:  He-Li Ding; Hua Cheng; Zu-Zhi Fu; Qing-Li Deng; Li YanLAST_NAME> Tang Yan; Tang Yan
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.